This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness
cocoparisienne / Pixabay

This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness

According to a story from Kamloops Coffee Talk, Darrin Rein, of Kamloops, British Columbia, was just recently diagnosed with spinocerebellar ataxia, a rare disease that affects mobility and coordination. Despite…

Continue Reading This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness

Could Stopping Using the Word “Rare” Increase the Rate of Diagnosis for Rare Disease Patients?

The Word "Rare" Unfortunately, many experts in rare disease believe the phrase "rare disease" may be harming the very population it describes. The Director of the National Center for Advancing…

Continue Reading Could Stopping Using the Word “Rare” Increase the Rate of Diagnosis for Rare Disease Patients?

After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear

According to a story from BioSpace, a Phase 1/2 clinical trial testing SGT-001, an investigational treatment for Duchenne muscular dystrophy, has been plagued by problems with side effects and adverse…

Continue Reading After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear
Tel Aviv University Awards Honorary Doctorate to Researcher Who Played Critical Role in Developing Spinal Muscular Atrophy Drug
kkolosov / Pixabay

Tel Aviv University Awards Honorary Doctorate to Researcher Who Played Critical Role in Developing Spinal Muscular Atrophy Drug

According to a story from The Jerusalem Post, Adrian Krainer is a prominent molecular geneticist and biochemist. His research was also pivotal in developing the first-ever disease modifying treatment for…

Continue Reading Tel Aviv University Awards Honorary Doctorate to Researcher Who Played Critical Role in Developing Spinal Muscular Atrophy Drug
FDA Approves Investigational New Drug Application for Experimental Fabry Disease Therapy
https://pixabay.com/en/thumbs-up-okay-good-well-done-2056022/

FDA Approves Investigational New Drug Application for Experimental Fabry Disease Therapy

According to a publication from Fabry Disease News, the U.S. Food and Drug Administration (FDA) has approved American biotechnology company Avrobio's Investigational New Drug (IND) application for experimental Fabry disease…

Continue Reading FDA Approves Investigational New Drug Application for Experimental Fabry Disease Therapy

Resort City in California has Made Their Beaches Wheelchair Accessible with Temperature Controlled Mats

Coronado is a resort city located in San Diego, California. It's known for its luxury hotels, delicious restaurants, beautiful parks, and gorgeous beaches. It has just been announced that the…

Continue Reading Resort City in California has Made Their Beaches Wheelchair Accessible with Temperature Controlled Mats

Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

SCID Severe combined immunodeficiency (SCID) is a rare disease which causes patients to have little to no immune response. With practically no immune system, SCID patients are very susceptible to…

Continue Reading Family is Searching for an Eligible Bone Marrow Donor for Their Infant with Severe Combined Immunodeficiency

Learn About These Rare Eye Diseases to Honor Healthy Vision Month!

May is Healthy Vision Month! Rare disease or not, maintaining healthy eye health should be a priority for all of us. The National Institute of Health has resources for not…

Continue Reading Learn About These Rare Eye Diseases to Honor Healthy Vision Month!

Two Sisters with Rare Conditions Founded The Fighting H.A.R.D. Foundation to Help Other Patients Feel Less Alone

The Origins of Fighting H.A.R.D. The Fighting H.A.R.D. Foundation was established in 2015 by two sisters who both live with multiple rare diagnoses. 16-year-old Allie is diagnosed with juvenile rheumatoid…

Continue Reading Two Sisters with Rare Conditions Founded The Fighting H.A.R.D. Foundation to Help Other Patients Feel Less Alone

Experimental Treatment for Genetic Amyotrophic Lateral Sclerosis Shows Potential in Trial

According to a story from BioSpace, the drug developer Biogen recently released interim results from a Phase 1/2 clinical trial. This clinical trial is testing the drug tofersen, which is…

Continue Reading Experimental Treatment for Genetic Amyotrophic Lateral Sclerosis Shows Potential in Trial

The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research

PREFER PREFER stands for Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle. It is a multi-stage project developed by Newcastle University's Welcome Centre for Mitochondrial Research in effort…

Continue Reading The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research
Study Finds Similar Survival Rates in Idiopathic and Disease Associated Pulmonary Arterial Hypertension
1643606 / Pixabay

Study Finds Similar Survival Rates in Idiopathic and Disease Associated Pulmonary Arterial Hypertension

According to a story from Pulmonary Hypertension News, a recent study found that patients with disease-associated pulmonary arterial hypertension had similar rates of survival compared to patients with idiopathic pulmonary…

Continue Reading Study Finds Similar Survival Rates in Idiopathic and Disease Associated Pulmonary Arterial Hypertension

Cystic Fibrosis Patient Goes “From Bed-Bound and Tube-Fed to School-Attending and Sushi-Eating” with Engineered Phage Therapy

Phage Therapy Phages, or bacteriophages, are the natural enemy of viruses. They are the most abundant organisms in the biosphere. Researchers have used phages as treatments before, however after the…

Continue Reading Cystic Fibrosis Patient Goes “From Bed-Bound and Tube-Fed to School-Attending and Sushi-Eating” with Engineered Phage Therapy

After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear

According to a story from BioSpace, a Phase 1/2 clinical trial testing SGT-001, an investigational treatment for Duchenne muscular dystrophy, has been plagued by problems with side effects and adverse…

Continue Reading After Issues With Adverse Events, the Future of This Experimental Duchenne Muscular Dystrophy Drug Remains Unclear